GSK Investigational Site

Bankstown, New South Wales 22000

0 studies enrolling now · 5 studies all time

What they study most

Crohn's Disease, Pulmonary Disease, Chronic Obstructive

Studies at this site

• An Active Treatment Study to Induce Clinical Response and/or Remission With GSK1605786A in Subjects With Crohn's Disease — Stopped early
• A Study to Investigate the Efficacy and Safety of GSK1605786A in the Treatment of Subjects With Moderately-to-Severely Active Crohn's Disease — Completed
• Open-Label Extension Study of GSK1605786A — Stopped early
• GSK1605786A in the Maintenance of Remission in Subjects With Crohn's Disease — Stopped early
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed